PATTIES FOODS - Asset Resilience Ratio

Latest as of December 2025: 12.15%

PATTIES FOODS (PH4) has an Asset Resilience Ratio of 12.15% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€165.00 Million
≈ $192.90 Million USD Cash + Short-term Investments

Total Assets

€1.36 Billion
≈ $1.59 Billion USD All company assets

Resilience Assessment

Moderate
Financial Resilience Level

Asset Resilience Ratio Trend (2020–2025)

This chart shows how PATTIES FOODS's Asset Resilience Ratio has changed over time. See PATTIES FOODS financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Liquid Assets Composition Over Time

This chart breaks down PATTIES FOODS's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see PH4 stock market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €165.00 Million 12.15%
Total Liquid Assets €165.00 Million 12.15%

Asset Resilience Insights

  • Moderate Liquidity: PATTIES FOODS has 12.15% of assets in liquid form.
  • While adequate for normal operations, this level may limit flexibility during economic stress.
  • The company has significant short-term investments, indicating active treasury management.

PATTIES FOODS Industry Peers by Asset Resilience Ratio

Compare PATTIES FOODS's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
argenx NV ADR
NASDAQ:ARGX
Biotechnology 10.93%
Abivax SA
PA:ABVX
Biotechnology 2.34%
Genscript Biotech Corporation
F:G51
Biotechnology 13.79%
Zealand Pharma A/S
CO:ZEAL
Biotechnology 63.98%
ZAI LAB LTD0000006
F:1ZLB
Biotechnology 0.91%
Jiangxi Fushine Pharmaceutical Co Ltd
SHE:300497
Biotechnology 0.02%
Galapagos N.V.
AS:GLPG
Biotechnology 86.45%
Chengdu Easton Biopharmaceuticals Co Ltd
SHG:688513
Biotechnology 34.30%

Annual Asset Resilience Ratio for PATTIES FOODS (2020–2025)

The table below shows the annual Asset Resilience Ratio data for PATTIES FOODS.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 12.15% €165.00 Million
≈ $192.90 Million
€1.36 Billion
≈ $1.59 Billion
-8.31pp
2024-12-31 20.45% €285.00 Million
≈ $333.19 Million
€1.39 Billion
≈ $1.63 Billion
+18.65pp
2023-12-31 1.81% €30.00 Million
≈ $35.07 Million
€1.66 Billion
≈ $1.94 Billion
-27.70pp
2022-12-31 29.50% €483.41 Million
≈ $565.15 Million
€1.64 Billion
≈ $1.92 Billion
-13.80pp
2021-12-31 43.30% €983.62 Million
≈ $1.15 Billion
€2.27 Billion
≈ $2.66 Billion
+33.50pp
2020-12-31 9.81% €369.00 Million
≈ $431.39 Million
€3.76 Billion
≈ $4.40 Billion
--
pp = percentage points

About PATTIES FOODS

F:PH4 Germany Biotechnology
Market Cap
$1.10 Billion
€938.78 Million EUR
Market Cap Rank
#8613 Global
#1118 in Germany
Share Price
€0.59
Change (1 day)
-2.07%
52-Week Range
€0.46 - €1.35
All Time High
€1.35
About

CStone Pharmaceuticals, a biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally. The company offers CEJEMLY (sugemalimab), a monoclonal antibody against programmed death (PD) ligand 1 for the treatment of non-small cell lung cancer (NSCLC), gastric adenocarcinoma/gastroesophageal junctio… Read more